Inhibition by oral N-acetylcysteine of cigarette smoke-induced "bronchitis" in the rat

Exp Lung Res. 1986;10(3):267-83. doi: 10.3109/01902148609061497.


Specific pathogen-free rats were exposed to the cigarette smoke (CS) of 25 cigarettes daily for 14 days and concurrently given N-acetylcysteine (Nac) as 1% of their drinking water (average daily dose 973 mg/kg). The thickness of the epithelium was measured at four airway levels and the numbers of mucus-containing secretory cells, stained for neutral or acidic glycoprotein (NGP or AGP respectively), were counted in surface epithelium at eight airway levels. Cigarette smoke increased the thickness of the epithelium at three of the airway levels studied by between 37 and 72%. The number of secretory cells was increased at all airway levels distal to the upper trachea by between 102 and 421%. Secretory cells containing NGP were reduced in number but this was more than offset by a large increase in the number of secretory cells containing AGP at all airway levels. N-acetylcysteine inhibited CS-induced epithelial thickening. Nac also inhibited the CS-induced increase in the number of secretory cells with AGP, but had little effect on the CS-induced reduction in the number of cells with NGP. Thus, prophylactic oral N-acetylcysteine led to an overall inhibition of CS-induced mucous cell hyperplasia and epithelial hypertrophy. The results suggest a novel anti-inflammatory action for a drug with known mucolytic effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / therapeutic use*
  • Administration, Oral
  • Animals
  • Bronchitis / etiology
  • Bronchitis / prevention & control*
  • Cell Count
  • Epithelial Cells
  • Glycoproteins / metabolism
  • Intracellular Fluid / metabolism
  • Lung / cytology
  • Lung / metabolism
  • Male
  • Plants, Toxic*
  • Rats
  • Rats, Inbred Strains
  • Smoke / adverse effects*
  • Tobacco*
  • Trachea / cytology


  • Glycoproteins
  • Smoke
  • Acetylcysteine